This is the text extract for September 2008 Tender notification, browse documents here.

---

FAX

Tender Results

To: From: Date: All Suppliers and Wholesalers Yvonne Chen 30 September 2008 No of Pages (including this one): 4

Dear Supplier/Wholesaler

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 15 December 2006. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 10th October 2008. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2007/08 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes on 1 November 2008 and Sole Subsidised Supply commences on 1 February 2009.

The decisions were as follows:

Chemical Name Promethazine Hydrochloride Promethazine Hydrochloride Prednisone* Zopiclone

Presentation; Pack size and type Tab 10 mg; 50 tablets, blister Tab 25 mg; 50 tablets, blister Tab 20 mg; 500 tablets, bottle Tab 7.5 mg; 500 tablets, bottle

Current Subsidy $2.75 $4.50 $30.56 $22.13

New tender subsidy $2.72 $4.44 $29.03 $21.02

Sole supply brand (Supplier) Allersoothe (AFT) Allersoothe (AFT) Apo-Prednisone (Apotex) Apo-Zopiclone (Apotex)

*Sole Subsidised Supply for prednisone 20 mg tablets will commence on 1 January 2009, to be consistent with the other strengths of prednisone.

2. Tenders awarded to pharmaceuticals where at least one other brand is listed – subsidy changes for tender winning brand at the tender subsidy will occur on 1 November 2008, reference pricing of nontender winning brand will occur on 1 January 2009 and Sole Subsidised Supply commences on 1 April 2009.

The decisions were as follows:

A204177 - qA7633

---

Chemical Name Amoxycillin Amoxycillin Amoxycillin Amoxycillin Aqueous Cream Ciprofloxacin

Presentation; Pack size and type Drops 100 mg per 1 ml; 30 ml OP, bottle Inj 250 mg; 10 injections, vial Inj 500 mg; 10 injections, vial Inj 1 g; 10 injections, vial Crm; 500 g, pot Tab 250 mg; 30 tablets, blister

Current subsidy $7.25 $12.64 $14.46 $22.00 $2.37 $5.46

New tender subsidy $4.00 $12.42 $14.24 $21.62 $2.28 $3.35

Sole supply brand (Supplier) Ospamox (Sandoz) Ibiamox (Douglas) Ibiamox (Douglas) Ibiamox (Douglas) AFT (AFT) Rex Medical (Rex Medical) Rex Medical (Rex Medical) Rex Medical (Rex Medical) Hospira (Hospira) Hospira (Hospira) Hospira (Hospira)

Brands affected by reference pricing and delisting Amoxil Paediatric Drops (GSK) Ibiamox (Douglas)* Ibiamox (Douglas)* Ibiamox (Douglas)* Multichem (Multichem) Cipflox (Pacific)

Ciprofloxacin

Tab 500 mg; 30 tablets, blister

$8.90

$4.90

Cipflox (Pacific)

Ciprofloxacin Octreotide Octreotide Octreotide

Tab 750 mg; 30 tablets, blister Inj 50 mcg per ml, 1 ml; 5 injections, vial Inj 100 mcg per ml, 1 ml; 5 injections, vial Inj 500 mcg per ml, 1 ml; 5 injections, vial

$20.68 $43.50 $81.00 $399.00

$7.54 $25.65 $48.50 $175.00

Cipflox (Pacific) Sandostatin (Novartis) Sandostatin (Novartis) Sandostatin (Novartis)

*In a pack size of 5 injections

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 November 2008; DV Limits and DV Pharmaceuticals will apply from 1 January 2009.

The decisions were as follows:

Chemical Name Amoxycillin* Amoxycillin* Amoxycillin* Bupivacaine Hydrochloride with Fentanyl Bupivacaine Hydrochloride with Fentanyl Bupivacaine Hydrochloride with Fentanyl Bupivacine Hydrochloride with Fentanyl Morphine Sulphate Morphine Sulphate Morphine Sulphate Morphine Sulphate

Presentation; Pack size and type Inj 250 mg; 10 injections, vial Inj 500 mg; 10 injections, vial Inj 1 g; 10 injections, vial Inj 0.125% with 2 mcg fentanyl per ml, 15 ml; 10 injections, syringe Inj 0.125% with 2 mcg fentanyl per ml, 20 ml; 10 injections, syringe Inf 0.125% with 2 mcg fentanyl per ml, 100 ml; 10 infusions, bag Inf 0.125% with 2 mcg fentanyl per ml, 200 ml; 10 infusions, bag Inj 1 mg per ml, 10 ml; 10 injections, syringe Inj 1 mg per ml, 30 ml; 10 injections, syringe Inj 1 mg per ml, 50 ml; 10 injections, syringe Inj 2 mg per ml, 30 ml; 10 injections, syringe

Hospital Supply Brand (Supplier) Ibiamox (Douglas) Ibiamox (Douglas) Ibiamox (Douglas) Biomed (Biomed) Biomed (Biomed)

Pack Price $12.42 $14.24 $21.62 $61.50 $78.00

DV Limit 1% 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) (B) (B) (B) (B)

Biomed (Biomed)

$200.00

1%

(B)

Biomed (Biomed) Biomed (Biomed) Biomed (Biomed) Biomed (Biomed) Biomed (Biomed)

$200.00 $34.50 $75.00 $59.50 $95.00

1% 1% 1% 1% 1%

(B) (B) (B) (B) (B)

*Currently in a pack size of 5 injections.

A204177 - qA7633 2 of 4

---

4. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – price changes for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 November 2008; DV Limits and DV pharmaceuticals will apply from 1 January 2009; Delisting of other brands in Section H will occur on 1 January 2009.

Chemical Name Ciprofloxacin Ciprofloxacin Ciprofloxacin Octreotide Octreotide Octreotide Presentation; Pack size and type Tab 250 mg; 30 tablets, blister Tab 500 mg; 30 tablets, blister Tab 750 mg; 30 tablets, blister Inj 50 mcg per ml, 1 ml; 5 injections, vial Inj 100 mcg per ml, 1 ml; 5 injections, vial Inj 500 mcg per ml, 1 ml; 5 injections, vial Hospital Supply Brand (Supplier) Rex (Rex Medical) Rex (Rex Medical) Rex (Rex Medical) Hospira (Hospira) Hospira (Hospira) Hospira (Hospira) Pack Price $3.35 $4.90 $7.54 $25.65 $48.50 $175.00 DV Limit 1% 1% 1% 1% 1% 1% DV Pharmaceuticals Brand Name (Supplier) Cipflox (Pacific) Ciproxin (Bayer) Cipflox (Pacific) Ciproxin (Bayer)) Cipflox (Pacific) Ciproxin (Bayer) Sandostatin (Novartis) Sandostatin (Novartis) Sandostatin (Novartis)

5. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 November 2008 and DV Limits and DV Pharmaceuticals will apply from 1 January 2009.

The decisions were as follows:

Chemical Name Amoxycillin Promethazine Hydrochloride Promethazine Hydrochloride Prednisone*

Presentation; Pack size and type Drops 100 mg per 1 ml; 30 ml, bottle Tab 10 mg; 50 tablets, blister Tab 25 mg; 50 tablets, blister Tab 20 mg; 500 tablets, bottle

Hospital Supply Brand (Supplier) Ospamox (Novartis) Allersoothe (AFT) Allersoothe (AFT)

Pack Price $4.00 $2.72 $4.44

DV Limit 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) Amoxil Paediatric Drops (GSK) Phenergan (Sanofi-Aventis) Phenergan (Sanofi-Aventis)

Apo-Prednisone Douglas (Douglas) $29.03 1% (Apotex) Origen (GSK) Apo-Zopiclone Zopiclone Tab 7.5 mg; 500 tablets, bottle $21.02 1% Imovane (Sanofi-Aventis) (Apotex) *DV Limits and DV Pharmaceuticals for prednisone 20 mg tablets will apply from 1 December 2008, to be consistent with the other strengths of prednisone.

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 21 December 2007.

The decisions were as follows:

Chemical Name Etoposide Phosphate Triazolam Triazolam

Line Item Inj 100 mg (of etoposide base) Tab 125 mcg Tab 250 mcg

2006/07 Tender 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – subsidy changes for tender winning brand at the tender subsidy will occur on 1 November 2008, reference pricing of non-

A204177 - qA7633 3 of 4

---

tender winning brand will occur on 1 January 2009 and Sole Subsidised Supply commences on 1 April 2009.

The decisions were as follows:

Chemical Name Clotrimazole

Presentation; Pack size and type Vaginal crm 2% with applicator(s); 20 g OP, tube

Current subsidy $3.99

New tender subsidy $2.75

Brands affected by reference pricing and delisting Clotrimaderm 2% Clomazol (Multichem) (AFT)

Sole supply brand (Supplier)

2. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 November 2008 and DV Limits and DV Pharmaceuticals will apply from 1 January 2009.

The decisions were as follows:

Chemical Name Clotrimazole

Presentation; Pack size and type Vaginal crm 2% with applicator(s); 20 g OP, tube

Hospital Supply Brand (Supplier) Clomazol (Multichem)

Pack Price $2.75

DV Limit 1%

DV Pharmaceuticals Brand Name (Supplier) Canesten (Bayer) Clotrimaderm 2% (AFT)

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to tender dated 15 December 2006 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. Yours sincerely

Yvonne Chen Tender Analyst

A204177 - qA7633 4 of 4